PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

PETACH TIKVA, Israel , July 30, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2025 financial results and operational highlights before the